Hitoshi Suzuki

11.8k total citations · 1 hit paper
271 papers, 7.2k citations indexed

About

Hitoshi Suzuki is a scholar working on Nephrology, Immunology and Hematology. According to data from OpenAlex, Hitoshi Suzuki has authored 271 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Nephrology, 64 papers in Immunology and 49 papers in Hematology. Recurrent topics in Hitoshi Suzuki's work include Renal Diseases and Glomerulopathies (126 papers), Platelet Disorders and Treatments (37 papers) and Autoimmune Bullous Skin Diseases (27 papers). Hitoshi Suzuki is often cited by papers focused on Renal Diseases and Glomerulopathies (126 papers), Platelet Disorders and Treatments (37 papers) and Autoimmune Bullous Skin Diseases (27 papers). Hitoshi Suzuki collaborates with scholars based in Japan, United States and Czechia. Hitoshi Suzuki's co-authors include Jan Novák, Yusuke Suzuki, Bruce A. Julian, Yasuhiko Tomino, Robert Wyatt, Zina Moldoveanu, Jiří Městecký, Ali G. Gharavi, Mitsuaki Hosoya and Matthew B. Renfrow and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Hitoshi Suzuki

252 papers receiving 7.0k citations

Hit Papers

The Pathophysiology of Ig... 2011 2026 2016 2021 2011 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hitoshi Suzuki 4.5k 2.0k 1.6k 1.5k 1.3k 271 7.2k
Georges Deschênes 3.4k 0.8× 2.3k 1.1× 1.3k 0.8× 1.1k 0.8× 1.9k 1.4× 231 7.5k
Renato C. Monteiro 2.3k 0.5× 4.6k 2.3× 1.1k 0.7× 926 0.6× 1.9k 1.4× 173 8.9k
Hong Zhang 2.3k 0.5× 1.2k 0.6× 647 0.4× 845 0.6× 1.1k 0.8× 213 6.0k
Stephen R. Holdsworth 2.7k 0.6× 4.9k 2.4× 976 0.6× 479 0.3× 1.8k 1.3× 228 10.2k
Leendert A. van Es 3.1k 0.7× 4.1k 2.0× 1.3k 0.8× 636 0.4× 1.7k 1.3× 235 12.0k
Steven H. Sacks 2.4k 0.5× 5.8k 2.8× 968 0.6× 286 0.2× 1.4k 1.0× 256 9.6k
Bruno Moulin 1.9k 0.4× 1.4k 0.7× 662 0.4× 565 0.4× 654 0.5× 258 7.1k
Robert T. McCluskey 2.2k 0.5× 2.3k 1.1× 715 0.5× 713 0.5× 1.8k 1.4× 173 10.6k
Stephan Segerer 1.9k 0.4× 3.1k 1.6× 363 0.2× 368 0.3× 1.6k 1.2× 182 7.3k
John L. Decker 2.3k 0.5× 2.4k 1.2× 745 0.5× 988 0.7× 790 0.6× 106 7.9k

Countries citing papers authored by Hitoshi Suzuki

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Suzuki more than expected).

Fields of papers citing papers by Hitoshi Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Suzuki. The network helps show where Hitoshi Suzuki may publish in the future.

Co-authorship network of co-authors of Hitoshi Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Suzuki. A scholar is included among the top collaborators of Hitoshi Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Suzuki. Hitoshi Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukao, Yusuke, Hitoshi Suzuki, Yuko Makita, et al.. (2025). Plasmacytoid dendritic cells modulate the production of mucosal IgA in IgA nephropathy. Nephrology Dialysis Transplantation. 1 indexed citations
2.
T, Oda, et al.. (2024). Pediatric IgA-Dominant Infection-Related Glomerulonephritis. The Tohoku Journal of Experimental Medicine. 263(2). 97–104.
3.
Muto, Masahiro, et al.. (2024). New Insights and Future Perspectives of APRIL in IgA Nephropathy. International Journal of Molecular Sciences. 25(19). 10340–10340. 5 indexed citations
4.
Suzuki, Hitoshi, Yusuke Fukao, Tomoyuki Otsuka, et al.. (2024). Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy. Nephrology Dialysis Transplantation. 39(9). 1494–1503. 19 indexed citations
5.
Matsuzaki, Keiichi, Hitoshi Suzuki, Masao Kihara, et al.. (2024). Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan. Kidney360. 5(9). 1322–1332. 5 indexed citations
7.
Suzuki, Hitoshi, et al.. (2023). Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis. Clinical Kidney Journal. 16(Supplement_2). ii1–ii8. 20 indexed citations
9.
Suzuki, Hitoshi, Seiji Ueda, Yusuke Fukao, et al.. (2020). Sparsentan Protects Against Development of Albuminuria and Glomerulosclerosis in the gddY Mouse Model of IgA Nephropathy. Journal of the American Society of Nephrology. 31(10S). 564–564. 1 indexed citations
10.
Takao, Motoshi, et al.. (2012). Pulmonary foreign body granuloma on the staple line five years after wedge resection for metastatic lung cancer. The Journal of the Japanese Association for Chest Surgery. 26(1). 52–55. 4 indexed citations
11.
Suzuki, Hitoshi, Run Fan, Zhixin Zhang, et al.. (2009). Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. Journal of Clinical Investigation. 119(6). 1668–77. 341 indexed citations
12.
Konosu, Atsuhiro, et al.. (2009). Development Of A Biofidelic Flexible Pedestrian Legform Impactor Type Gtr Prototype, Part 1: Development And Technical Evaluations. 2009. 5 indexed citations
13.
Suzuki, Hitoshi, et al.. (2008). Anterior approach for pleuropnemonectomy and thoracoplasty in a patient with chronic expanding hematoma: a case report. The Journal of the Japanese Association for Chest Surgery. 22(1). 111–115. 2 indexed citations
14.
Suzuki, Hitoshi, et al.. (2005). A Case of Pacemaker (PM) Contact Sensitivity due to Silicon Allergy Which Occurred 24 Years after PM Implantation. Japanese Journal of Cardiovascular Surgery. 34(2). 124–126. 2 indexed citations
15.
Suzuki, Hitoshi, et al.. (2005). A Case of Stanford Type B Dissection with Limb Ischemia and Renal Disfunction Caused by Severely Compressed True Lumen. Japanese Journal of Cardiovascular Surgery. 34(4). 310–313. 1 indexed citations
16.
Suzuki, Hitoshi, et al.. (2005). A case of recurrent hemothorax associated with von Recklinghausen's disease. The Journal of the Japanese Association for Chest Surgery. 19(1). 71–74. 3 indexed citations
17.
Suzuki, Hitoshi, et al.. (2003). A Case of Combined Operation of Abdominal Aortic Aneurysm and Invasive Carcinoma of the Bladder. Japanese Journal of Cardiovascular Surgery. 32(5). 304–306.
18.
Morita, Çhiharu, et al.. (1994). Origin of Lymphocytic‐choriomeningitis‐virus‐bearing Mice in Japan. Journal of Veterinary Medicine Series B. 41(1-10). 291–293. 3 indexed citations
19.
Kawamura, Masaki, et al.. (1990). Altered Ca2+ transport of myocardial sarcolemma in diabetes mellitus. 37. 61–70. 1 indexed citations
20.
Suzuki, Hitoshi, et al.. (1989). [Immunological studies on the patients with Crohn's disease and a new attempt of interferon treatment].. PubMed. 86(2). 193–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026